Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
AI-driven approach identifies promising new target for CAR T cell therapy

AI-driven approach identifies promising new target for CAR T cell therapy

Higher BMI raises risk for 19 cancers as global review expands the obesity-cancer link

Higher BMI raises risk for 19 cancers as global review expands the obesity-cancer link

Novel technology maps single-cell DNA-protein interactions

Novel technology maps single-cell DNA-protein interactions

New all-oral regimen improves treatment convenience for AML patients

New all-oral regimen improves treatment convenience for AML patients

Novel CAR T treatment makes previously impossible kidney transplants possible

Novel CAR T treatment makes previously impossible kidney transplants possible

Roswell Park scientists present five key cancer studies at clinical meeting

Roswell Park scientists present five key cancer studies at clinical meeting

Small T-cell subset drives powerful multiple myeloma immunotherapy responses

Small T-cell subset drives powerful multiple myeloma immunotherapy responses

Restoring ADAR2 enzyme reduces metastatic spread in osteosarcoma

Restoring ADAR2 enzyme reduces metastatic spread in osteosarcoma

New therapies could help type 1 diabetes care move beyond insulin alone

New therapies could help type 1 diabetes care move beyond insulin alone

New FUSILLI tool improves gene fusion detection in pediatric leukemia

New FUSILLI tool improves gene fusion detection in pediatric leukemia

Scientists develop a superior diagnostic tool to spot hidden gene fusions in pediatric cancer

Scientists develop a superior diagnostic tool to spot hidden gene fusions in pediatric cancer

Loss of X chromosome linked to female infertility risk

Loss of X chromosome linked to female infertility risk

Diverse leukemia stem cells may drive AML relapse after therapy

Diverse leukemia stem cells may drive AML relapse after therapy

Long telomeres linked to higher lymphoma risk in families

Long telomeres linked to higher lymphoma risk in families

New genomic study tracks rare blood disease in children

New genomic study tracks rare blood disease in children

Food timing may shape how T cells respond to infection and therapy

Food timing may shape how T cells respond to infection and therapy

Gentler treatment improves survival in children with relapsed leukemia

Gentler treatment improves survival in children with relapsed leukemia

New CAR T cell design boosts persistence and reduces toxicity

New CAR T cell design boosts persistence and reduces toxicity

Maternal screening could help prevent deadly forms of leukemia

Maternal screening could help prevent deadly forms of leukemia

From killers to strategists: CAR T cells enter their multifunctional era

From killers to strategists: CAR T cells enter their multifunctional era

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.